Introduction
Normal tissue repair follows a sequence of events involving clotting, inflammation, granulation tissue formation and reepithelialization. 1, 2 Within few hours after injury, first polymorphonuclear neutrophils (PMN) and later macrophages (M) invade the wound tissue to combat contaminating organisms by producing proteases and reactive oxygen species (ROS).
By phagocytosing apoptotic PMN before these undergo secondary necrosis, M terminate the inflammatory phase and prevent spillage of toxic proteases and ROS that might amplify tissue injury. 3 After engulfment of PMN, M release transforming growth factor (TGF)-␤ 1 at the wound site, 3, 4 which initiates myofibroblast differentiation, wound contraction, and neo-angiogenesis. 4, 5 A large number of leukocyte and endothelial adhesion molecules are required to coordinately regulate the influx and intimate cell-to-cell interactions of distinct leukocyte subpopulations at wound sites. 4, 6 The ␤ 2 -integrins CD11a/CD18 (LFA-1), CD11b/ CD18 (Mac-1), CD11c/CD18 (gp 150,95), and CD11d/CD18 are constitutively expressed on the surface of leukocytes; these heterodimers consist of a common ␤ 2 subunit (CD18) and a variable ␣ subunit (CD11a, CD11b, CD11c, CD11d). 7 ␤ 2 -integrins are responsible for PMN recruitment 4, [8] [9] [10] [11] [12] and for the recruitment of M subsets 13 in different mouse models of inflammation. In addition, CD18 is crucial for the formation of the phagocytic synapse between M and apoptotic PMN 14 that initiates TGF-␤ 1 release and is essential for myofibroblasts differentiation 4 and vessel formation. 5 The importance of ␤ 2 -integrins is emphasized in leukocyte adhesion deficiency (LAD1) patients suffering from severe wound healing disturbances and bacterial infections due to decreased ␤ 2 -integrin expression and/or function. 15, 16 Also CD18 Ϫ/Ϫ mice share the essential characteristics of LAD1 patients. 4, 10 Thus, ␤ 2 -integrins are critical mediators of PMN and M functions in innate immunity and tissue repair. However, apart from a few downstream target proteins of ␤ 2 -integrin signaling such as the nonreceptor tyrosine kinase Syk activated by adaptors bearing immunoreceptor tyrosine based activation motifs (ITAMs), 17, 18 little is known on the CD18 downstream signaling in phagocytes.
The guanine-nucleotide exchange factors Vav couple to diverse signaling receptors and, due to their exchange activity and adaptor domains, are ideally suited to transduce signals to RhoGTPases and the actin cytoskeleton. [19] [20] [21] Targeted disruption of Vav1 results in severe impairment of T lymphocyte function in response to antigen receptor stimulation 19, 20 with defective TCR capping and actin patch formation. 21, 22 Various Vav double-knockout mice reveal distinctive B-and T-cell phenotypes, [23] [24] [25] and in case of Vav triple knockouts, the function of B and T cells is severely compromised. 25 Mainly in vitro evidence exists for Fc␥R, ␤ 1 , ␤ 2 and ␤ 3 -integrin-dependent roles for Vav proteins in T cells, 26 platelets, 27 neutrophils, [28] [29] [30] and M. 31, 32 To dissect carefully the in vivo role of Vav proteins for ␤ 2 -integrin-dependent PMN and M functions in cutaneous wound healing, we here used Vav1 Ϫ/Ϫ , Vav3 Ϫ/Ϫ , and Vav1 Ϫ/Ϫ /Vav3 Ϫ/Ϫ mice. We identify Vav3 as a critical downstream target in the CD18-dependent formation of the phagocytic synapse between M and PMN required for tissue repair.
Methods Mice
Vav1 Ϫ/Ϫ , Vav2 Ϫ/Ϫ , Vav3 Ϫ/Ϫ , Vav1 Ϫ/Ϫ /Vav3 Ϫ/Ϫ , Vav2 Ϫ/Ϫ /Vav3 Ϫ/Ϫ , and WT littermates were previously described. 24, 33 Wound-healing experiments were performed with male cohorts between 8 and 12 weeks of age. All experiments were carried out in compliance with the German Law for Welfare of Laboratory Animals and were approved by the Institutional Review Board of the University of Ulm.
Generation of bone marrow chimeras
Bone marrow chimeras were generated by intravenous injection of whole bone marrow cells from WT or Vav3 Ϫ/Ϫ mice on C57BL/6 (B6) background carrying the Ly5.2/CD45.2 allele, into lethally irradiated congenic recipients bearing the Ly5.1/CD45.1 allele on B6 background (The Jackson Laboratory, Bar Harbor, ME). Complete repopulation with either Vav3 Ϫ/Ϫ or WT leukocyte compartment was confirmed by flow cytometry and immunoblotting ( Figure S1A ,B, available on the Blood website; see the Supplemental Materials link at the top of the online article).
Wound-healing model
Wound-healing experiments were performed as described. 4 Briefly, fullthickness (including the panniculus carnosus) excisional wounds were produced under anesthesia with 6-mm round knives (Stiefel, Offenbach, Germany) on both sides of the shaved backs of
, and WT mice, and of WT or Vav3 Ϫ/Ϫ chimeras. Four wounds per mouse were induced. At indicated time points, each wound was digitally photographed, and wound areas were quantified using Adobe Photoshop software version 7.0.1 (Adobe Systems, San Jose, CA). Wound sizes at any time point were expressed as percentage of initial (day 0) wound area. For early time point analyses, wounds including adjacent margins were snap-frozen and stored at Ϫ80°C.
Immunofluorescence staining, Western blot analysis, and generation of murine bone marrow-derived M and apoptotic PMN Details of immunofluorescence staining, Western blot analysis, and generation of murine bone marrow-derived M and apoptotic PMN are contained in Document S1.
In vitro adhesion and phagocytosis assays
WT or Vav3 Ϫ/Ϫ mature M were plated to adhere onto 24-well cell culture plates (Nunc/Thermo Fisher Scientific, Langenselbold, Germany) before addition of CMRA-labeled apoptotic PMN from indicated genotypes at M:PMN ratio of 1:10. After 15 minutes of coculture for adhesion and 45 minutes for phagocytosis, nonadherent/ingested PMN were removed with cold phosphate-buffered saline (PBS). Adherent cells were collected by scraping and stained for the M marker F4/80. CMRA ϩ F4/80 ϩ double positive complexes either of M adherent to PMN or M phagocytosing PMN were quantified by flow cytometry as previously described. 4 
Macrophage adhesion assay
Ninety-six-well cell culture plates (Nunc) were coated with 20 g/mL fibronectin (BD Biosciences, Heidelberg, Germany), 20 g/mL rmICAM-1 or with 20 g/mL vitronectin (R&D Systems, Wiesbaden, Germany) overnight at 4°C. Bovine serum albumin (BSA; 0.1%)-coated wells served as controls for unspecific adhesion. BSA covered the plastic, reported to bind ␤ 2 -integrins, and thus abolished ␤ 2 -integrin-mediated adhesion. WT or Vav3 Ϫ/Ϫ 5-chloromethylfluorescein diacetate (CMFDA)-labeled M preactivated with 10 ng/mL TNF␣ (PeproTech, Hamburg, Germany) were seeded onto the coated plates at 5 ϫ 10 4 /well, shortly placed on ice to synchronize adhesion and incubated to adhere at 37°C for 15 minutes. Nonadherent cells were rigorously washed with PBS. Adhesion was assessed as percentage of fluorescence intensity related to total input macrophages (100%) measured at 485 nm with a Twinkle LB970 Fluorometer (Berthold Technologies, Bad Wildbad, Germany).
Oxidative burst
WT and Vav3 Ϫ/Ϫ M loaded with the ROS-sensitive fluorescence quenched substrate 5-(and 6)-carboxy-2Ј,7Ј-dichlorodihydrofluorescein diacetate (Invitrogen, Karlsruhe, Germany) were incubated with apoptotic PMN at 1:10 ratio for 180 minutes at 37°C. The increase in green fluorescence intensity reflecting oxidative burst was measured by fluorometry.
Immunoprecipitation
To study Vav3 activation, M lysates were immunoprecipitated with anti-Vav3 pAb (Millipore, Billerica, MA), followed by Western blotting using anti-Phosphotyrosine mAb (4G10;, Millipore). A detailed description is included in Document S1.
Rescue and transfer experiments
Recombinant human (rh) TGF-␤ 1 (R&D Systems) was subcutaneously injected at physiologic concentrations of 0.45 g/wound into wound margins at days 1, 3, 5 and 7 after wounding as published. 4 Mice treated with 0.9% saline served as mock controls. For transfer experiments, 10 6 WT, Vav3 Ϫ/Ϫ or CD18 Ϫ/Ϫ M/wound were injected at 4 sites into the wound margins of WT or Vav3 Ϫ/Ϫ mice. Control wounds were injected with PBS.
Cytokine enzyme-linked immunosorbent assay ELISA
Details of cytokine enzyme-linked immunosorbent assay (ELISA) appear in Document S1.
Binding of soluble ICAM-1
Bone marrow-derived WT, Vav3 Ϫ/Ϫ and CD18 Ϫ/Ϫ unstimulated (resting) or stimulated (with 100 nm fMLP, 100 nm LTB4; Sigma-Aldrich) or 50 ng/ mL TNF␣ (eBioscience, Frankfurt, Germany) M were incubated with 5 g rmICAM-1 fused to the Fc region of human IgG (ICAM-1/Fc; R&D Systems) in 100 L binding buffer (PBS, 2 mM MgCl2, 1 mM CaCl2, 1 mM D-Glucose and 0.1% BSA) at 37°C for 10 minutes with continuous agitation. M incubated with human IgG served as controls. M were immediately fixed on ice in 3.7% paraformaldehyde, washed in PBS and labeled with FITC-conjugated F(abЈ) anti-human IgG to detect bound ICAM-1 on M by flow cytometry. Bound ICAM-1/Fc was assessed as ratio between the mean fluorescence intensities of M incubated with ICAM-1/Fc and M incubated with human IgG for each stimulation.
Image acquisition and analysis
Wounds were photographed using a Sony Super SteadyShot DSC-H5 digital camera (Sony Germany, Berlin, Germany). Histology samples were visualized using a Zeiss Axiophot microscope with Plan-NEOFLUAR 20ϫ/0.75 (ϱ/0.17) objective and images were captured using AxioCam MRc camera and AxioVision Version 4.7 imaging software (all Carl Zeiss, Jena, Germany). Confocal microscopy was performed using LSM 410/ Axiovert 135M microscope (Zeiss) with Leica TCS SP% 63ϫ/1.2 oil objective (Leica Microsystems, Wetzlar, Germany). Images were imported 
Statistical analysis
Quantitative data are presented as mean values plus or minus standard deviation (SD). Statistical significance was determined by the 2-tailed Student t test, or the Mann-Whitney U test in cases of a non-Gaussian distribution. A P value less than .05 was considered statistically significant.
Results
Vav3 Ϫ/Ϫ mice display delayed wound healing with diminished numbers of M and normal PMN recruitment at the wound site Full-thickness wounds were produced on Vav1 Ϫ/Ϫ , Vav2 Ϫ/Ϫ , Vav3 Ϫ/Ϫ mice, intercrosses thereof, and WT controls. Wound sizes were monitored as described. 4 Wound closure of Vav3 Ϫ/Ϫ mice was significantly delayed between days 3 and 10 after wounding compared with WT mice ( Figure 1A,B Figure 1C and data not shown). Therefore, we concentrated on Vav3 Ϫ/Ϫ and for control purposes in selected experiments also on Vav1 Ϫ/Ϫ /Vav3 Ϫ/Ϫ mice.
Immunostaining for GR-1 revealed virtually no differences in PMN numbers at wound sites of Vav3 Ϫ/Ϫ and Vav1 Ϫ/Ϫ /Vav3 Ϫ/Ϫ compared with WT mice at 24 hours after wounding (Figure 2A ). Also at earlier (1 hour, 6 hours) and later (72 hours) time points, no obvious differences in PMN recruitment were observed for the studied genotypes (data not shown). By contrast, immunostaining of 72-hour wounds revealed a significant reduction in recruitment of F4/80 ϩ M to wound sites of Vav3 Ϫ/Ϫ and Vav1 Ϫ/Ϫ /Vav3 Ϫ/Ϫ compared with WT mice (Figure 2A ). These data were confirmed by fluorescence-activated cell sorting (FACS) quantification of GR-1 ϩ PMN enzymatically isolated from wound tissue 24 hours after wounding ( Figure 2B ) and of F4/80 ϩ M isolated 3 days after wounding ( Figure 2C ). The expression levels of apoptosis markers such as active caspase-3 and PARP-1 were identical in wounds of WT and Vav3 Ϫ/Ϫ mice at different time points (data not shown), suggesting that enhanced apoptosis was not responsible for the reduced M numbers at Vav3 Ϫ/Ϫ wound sites.
Wounds of Vav3 Ϫ/Ϫ mice reveal reduced numbers of myofibroblasts and blood vessels Differences in wound size between WT and Vav3 Ϫ/Ϫ mice were most significant between days 3 and 7 after wounding. While at day 3 the early inflammatory phase prevails, we have focused on days 5 and 7, when mainly myofibroblast-dependent wound contraction 34 and neo-angiogenesis occur, and studied the expression of myofibroblasts and endothelial cell markers in granulation tissues by histology and Western blotting. In 5-and 7-day-old wounds, the myofibroblast-specific ␣ smooth muscle actin (␣SMA) was abundantly present at wound edges and below the hyperproliferative epidermis of WT wounds. In contrast, only faint ␣SMA staining was detected in the correspondent areas of 5-and 7-day-old Vav3 Ϫ/Ϫ wounds ( Figure 2D ). Densitometric assessment of Western blots revealed lower expression of ␣SMA and another myofibroblast marker, TGF␤-RII, in wounds of Vav3 Ϫ/Ϫ mice compared with WT mice (Figure 2E,F) . Vimentin served to equilibrate loading for similar numbers of fibroblastic cells. These results suggested that lower numbers of myofibroblasts resided in wound beds of Vav3 Ϫ/Ϫ mice compared with WT mice.
Apart from myofibroblast-driven wound contraction, neoangiogenesis plays an important role in tissue repair. Notably, immunostaining for platelet/endothelial cell adhesion molecule 1 (PECAM-1) revealed high numbers of vessels in 5 and 7 days WT wounds, whereas significantly fewer PECAM-1 ϩ vessels were found in Vav3 Ϫ/Ϫ wounds ( Figure 2D ). This was confirmed by Western blotting using wound lysates of Vav3 Ϫ/Ϫ and WT mice ( Figure 2E ,F), suggesting that neo-angiogenesis is reduced and delayed in Vav3 Ϫ/Ϫ mice. ␣SMA, TGF␤-RII, and PECAM-1 in nonwounded normal skin were expressed at identical low levels in the studied Vav3 Ϫ/Ϫ and WT mice, excluding the possibility that these molecules are globally down-regulated in Vav3 Ϫ/Ϫ mice. 
org From
To provide evidence for a causal role of TGF-␤ 1 deficiency in the impaired wound closure, we injected rhTGF-␤ 1 (or NaCl as control) subcutaneously around the wounds as previously described. 4 Gross assessment ( Figure 3D ) and digital measurement ( Figure 3E ) of wound sizes during healing showed that local injection of rhTGF-␤ 1 fully rescued impaired wound healing of Vav3 Ϫ/Ϫ mice. Notably, in contrast to wounds of mock-treated Vav3 Ϫ/Ϫ mice with reduced ␣SMA, TGF␤-RII, and PECAM-1 expression, Vav3 Ϫ/Ϫ wounds injected with rhTGF-␤ 1 showed increased myofibroblast ␣SMA, TGF␤-RII, and vascular PE-CAM-1 levels in wound lysates ( Figure 3F ) and increased numbers of PECAM-1 ϩ cells in wound tissue sections ( Figure 3G ), comparable with wounds from WT controls. Thus, in absence of Vav3, injection of rhTGF-␤ 1 during healing was sufficient to fully restore myofibroblast-driven wound contraction and neo-angiogenesis, unequivocally supporting a causal role for the reduced release of active TGF-␤ 1 in the delayed wound healing of Vav3 Ϫ/Ϫ mice.
As TGF-␤ 1 has been reported to modulate M chemotaxis, 37 we investigated whether TGF-␤ 1 
Vav3 Ϫ/Ϫ PMN ( Figure 4A and data not shown). Instead, when coculturing WT M with Vav1 Ϫ/Ϫ /Vav3 Ϫ/Ϫ PMN, a minor, though significant, decrease in adhesion was observed. These data suggest that Vav3 deficiency in M is predominantly responsible for the observed adhesion defect, whereas in PMN a double Vav1/Vav3 deficiency is required to affect adhesion to some extent. In fact, previous reports confirm that Vav1 and Vav3 play redundant roles in PMN adhesion and spreading, functions that are only impaired by double deficiency. 28 Firm adhesion of target cells to phagocytes markedly contributes to phagocytic efficacy. 4 LAD1 patients and CD18 Ϫ/Ϫ mice, 4 and neither Vav3 Ϫ/Ϫ nor CD18 Ϫ/Ϫ M injected into wound margins of Vav3 Ϫ/Ϫ mice could rescue the wound healing defect (Figures 4D, 5E ). This may indicate that CD18 deficiency and Vav3 deficiency result in identical defects in M and, thus, suggest that CD18 and Vav3 are within the same signaling pathway controlling engulfment of PMN by M and active TGF-␤ 1 release. Therefore, we set out to further investigate whether Vav3 may qualify as a downstream target in the ␤ 2 -integrin (CD18)-dependent signaling in M.
Vav3 is a downstream target of ␤ 2 -integrin-dependent M adhesion
As the physical attachment of M to apoptotic PMN depends on ␤ 2 -integrins, we studied the adhesive property of WT and Vav3 Ϫ/Ϫ M onto the ␤ 2 -integrin ligand intercellular adhesion molecule 1 (ICAM-1), which mediates ␤ 2 -integrin-dependent formation of the phagocytic synapse 4 ( Figure S2A ). Integrin-mediated M activation was achieved by TNF␣ stimulation before plating on defined ligands. Comparable CD18 expression levels were confirmed for WT and Vav3 Ϫ/Ϫ M and PMN before and after TNF␣ stimulation as assessed by flow cytometry ( Figure S2D and data not shown). Notably, Vav3 Ϫ/Ϫ M revealed a significantly reduced adhesion to ICAM-1 compared with WT M. This Vav3-dependent ␤ 2 -integrinmediated adhesion to ICAM-1 was specific, as adhesion of both WT and Vav3 Ϫ/Ϫ M to BSA was insignificant. Compared with the ␤ 2 -integrin-dependent reduced adhesion to ICAM-1, a minor, but significant decrease in adhesion was detected when Vav3 Ϫ/Ϫ M were plated onto the ␤ 3 -integrin ligand vitronectin, indicating that Vav3, at least in part, controls ␤ 3 -integrin-dependent M adhesion. This finding is in line with previous reports indicating Vav3 to control ␣ v ␤ 3 -dependent polarization and spreading of osteoclasts. 32 By contrast, Vav3 deficiency did not affect ␤ 1 -integrin-mediated binding to fibronectin, suggesting that Vav3 is preferentially responsible for ␤ 2 -integrin-mediated M adhesion and, to a lesser extent, contributes to ␤ 3 -integrin-mediated M adhesion ( Figure 5A ).
Moreover, these findings suggested a role for Vav3 in ␤ 2 -integrin-dependent strengthening of the synapse between M and PMN, which depends on ICAM-1 binding. To investigate the contribution of Vav3 to ␤ 2 -integrin activation in more detail, we assessed ␤ 2 -integrin affinity of WT, Vav3 Ϫ/Ϫ and CD18 Ϫ/Ϫ M by their capacity to bind soluble ICAM-1 (sICAM-1). Activated WT M bound sICAM-1 up to 4 times more efficiently compared with unstimulated or to CD18 Ϫ/Ϫ M. Remarkably, in the absence of Vav3 the capacity of M to bind sICAM-1 was diminished to 50% when stimulated with fMLP and to 30% when activated by TNF␣ ( Figure 5B ). These results strongly suggest that Vav3 controls integrin affinity upon activation and thus regulates the extent of outside-in signaling required for firm adhesion, phagocytosis and oxidative burst.
To further characterize the role of Vav3 as a downstream target of ␤ 2 -integrin-dependent signaling in M, we analyzed the cellular localization of Vav3 and CD18 during M adhesion on ICAM-1 using confocal microscopy. CD18 ( Figure 5C second top panel, red) redistributed and clustered within focal adhesion contacts ( Figure 5C second top panel, open arrows) at the cell membrane when M were plated onto the ␤ 2 -integrin specific ligand ICAM-1, which is also present in the phagocytic synapse ( Figure 5C ). In more than 60% of the M, Vav3 ( Figure 5C third top panel, green) colocalized with CD18 at focal adhesion sites as revealed by the yellow staining indicated with filled arrows ( Figure 5C fourth top  panel) . In contrast, no stringent colocalization of CD29 (␤ 1 -integrins) with Vav3 was observed when M were plated onto fibronectin ( Figure 5C bottom panels), suggesting that Vav3 is not involved in the ␤ 1 -integrin-dependent adhesion, but in the ␤ 2 -integrindependent adhesion to ICAM-1 and, thus, in the phagocytic cup formation.
Activation of Vav proteins requires phosphorylation of specific tyrosine residues as a prerequisite to activate downstream targets. So far, integrin signaling via Vav3 has rarely been addressed in M. 31, 32 To study whether Vav3 is activated in response to ␤ 2 -integrin engagement, the phosphorylation status of Vav3 after M binding to ICAM-1 was assessed. Before adhesion, M were treated with TNF␣ to enhance integrin adhesive activity. No phosphorylation occurred upon TNF␣ treatment when M were plated on BSA-coated dishes, excluding any direct effect of TNF␣ on the phosphorylation status of Vav3 (data not shown). Induction of Vav3 phosphorylation was observed at 10 minutes after plating M onto ICAM-1, whereas the level of total Vav3 remained unchanged ( Figure 5D ).
Additional evidence for the ␤ 2 -integrin-dependent Vav3 activation was provided by the observation that CD18hypomorphic M (with only 15% of CD18 WT expression levels 39 ) revealed significantly reduced Vav3 phosphorylation upon adherence on ICAM-1, whereas CD18 Ϫ/Ϫ M attached poorly and could not be harvested in sufficient quantities (unpublished data).
These data, together with the finding that, similar to injection of Vav3 Ϫ/Ϫ M, injection of CD18 Ϫ/Ϫ M in wound margins does not restore the impaired wound healing of Vav3 Ϫ/Ϫ mice ( Figure 5E ), suggest that Vav3 in M constitutes a key molecule in the ␤ 2 -integrin-dependent formation of a functional phagocytic synapse essentially required for proper wound healing.
Discussion
We here found Vav3 proteins to be specifically required for proper healing of cutaneous full-thickness wounds, whereas their absence results in delayed angiogenesis and impaired wound closure. This phenotype closely resembles nonhealing wounds in LAD1 patients with functional mutations in the CD18 gene 16, 40 and CD18 Ϫ/Ϫ mice. 4 The impaired wound closure in Vav3 Ϫ/Ϫ mice is essentially due to a ␤ 2 -integrin-dependent deficient formation of the phagocytic synapse between Vav3 Ϫ/Ϫ M and apoptotic PMN. The defective engulfment of PMN leads to reduced release of active TGF-␤ 1 from M, which in turn is responsible for defective myofibroblast-driven wound contraction and reduced angiogenesis. Injection of either recombinant TGF-␤ 1 or Vav3 competent M into wound margins of Vav3 Ϫ/Ϫ mice fully rescued the defective wound healing.
We here identified a previously unrecognized role for Vav3 in M, linking to a central role for Vav3 in ␤ 2 -integrin downstream signaling in M, which, if defective, may contribute to disturbances in tissue repair and host defense in general. In particular, between days 5 and 7 after wounding, the phase of granulation tissue contraction and neo-angiogenesis, Vav3 Ϫ/Ϫ wounds were significantly larger compared with WT wounds. Reduced ␣SMA and TGF␤-RII expression in Vav3 Ϫ/Ϫ granulation tissue suggest that, similar to CD18 deficiency, 4 impaired wound closure in Vav3 Ϫ/Ϫ mice results from reduced myofibroblasts differentiation. Myofibroblasts differentiation is characterized by the de novo expression of ␣SMA, conferring wound contraction in vivo 41 and in vitro. 42, 43 TGF-␤ 1 is the major growth factor inducing ␣SMA ϩ myofibroblast differentiation 44 through specific binding to TGF␤-RII. 45 TGF-␤ 1 amplifies its response via an autocrine For personal use only. on October 18, 2017. by guest www.bloodjournal.org From mechanism with up-regulation of TGF␤-RII and enhanced release of active TGF-␤ 1 from myofibroblasts and inflammatory cells. Therefore, decreased TGF-␤ 1 release from M in the initial phases of wound healing will result in substantially amplified effects on myofibroblasts differentiation and angiogenesis 5, 44 driving tissue repair. We here demonstrate that reduced active TGF-␤ 1 in granulation tissue of Vav3 Ϫ/Ϫ mice is the major pathogenic event in impaired wound healing, since wound contraction is fully rescued after subcutaneous injection of rhTGF-␤ 1 . TGF-␤ 1 release from M is essentially induced upon phagocytosis of apoptotic PMN at wound sites. 3, 4 As both PMN and M are mandatory for the formation of the phagocytic synapse with sufficient TGF-␤ 1 release, we studied their emigration patterns. M recruitment at wound sites was reduced in Vav3 deficiency; however, the recruitment defect was similar in Vav3 Ϫ/Ϫ and Vav1 Ϫ/Ϫ ; Vav3 Ϫ/Ϫ mice, suggesting that Vav3 alone is critical for the M extravasation to wound sites. This is in line with previous data reporting Vav3 to control cytoskeleton organization, polarization and spreading of M 32 or MCS-F-induced M chemotaxis, 46 all critical functions for M emigration. Irrespective of the underlying mechanism, defective M recruitment was not causal for the impaired wound healing in Vav3 Ϫ/Ϫ mice, as circumventing this defect by injection of Vav3 Ϫ/Ϫ M directly into the wound margin failed to rescue the healing disturbance. However, differences in the recruitment of M and PMN between Vav3 Ϫ/Ϫ and the ␤ 2 -integrin(CD18) Ϫ/Ϫ mice may explain the earlier onset of the wound healing delay in Vav3 Ϫ/Ϫ mice compared with CD18 Ϫ/Ϫ mice (see also "Discussion" section of online data supplement).
In this report, we define the defective formation of the phagocytic synapse between Vav3 Ϫ/Ϫ M and apoptotic PMN as the major cause for the reduced release of active TGF-␤ 1 Possibly, the diminished oxidative burst in Vav3 Ϫ/Ϫ M upon phagocytosis of apoptotic PMN contributes to the reduced TGF-␤ 1 activation and consequences thereof. In fact, activation of TGF-␤ 1 has been reported to be mediated by ROS, 36 and VaV guanin nucleotide exchange factors link integrin-mediated signaling with the assembly of the nicotinamid-adenin dinucleotide phosphate oxidase complex responsible for the production of ROS in M. 47 The almost identical phenotypes with delayed wound closure, defective phagocytic synapse formation and reduced release of active TGF-␤ 1 in CD18 Ϫ/Ϫ and Vav3 Ϫ/Ϫ mice very much suggest that ␤ 2 -integrins may preferentially control these key steps via the guanine exchange factor Vav3 in M. Several lines of evidence support this view.
First, ␤ 2 -integrins are mandatory for the attachment-mediated phagocytosis of PMN by M and for the phagocytic synapse formation. For this, binding of Mac-1 (CD11b/CD18) on M to its counterreceptor ICAM-1 on PMN and vice versa are essential. 4 In case Vav3 constituted a downstream target of CD18, we predicted that Vav3 Ϫ/Ϫ M would display reduced adhesion to ICAM-1. And exactly that is what we found. By contrast, Vav3 Ϫ/Ϫ M adhesion onto fibronectin, a ␤ 1 -integrin-dependent ligand, was not altered, strongly suggesting a critical role for Vav3 in ␤ 2 -integrindependent M adhesion. Even though we found a decrease in adhesion of Vav3 Ϫ/Ϫ M to the ␤ 3 -integrin ligand vitronectin, suggesting that Vav3 plays a role in ␤ 3 -integrin signaling. Vitronectin is an extracellular matrix protein that does not occur at the synapse between M and apoptotic PMN, and thus may not be relevant in the phagocytic cup formation studied here. In fact, ␤ 3 -integrins/CD36 complexes interact with unknown moieties on PMN via a thrombospondin bridge. 48 In support of Vav3 preferentially relaying ␤ 2 -integrin-mediated signals, Vav3 distinctly controlled the M capacity to bind ␤ 2 -integrin-specific ligands upon activation, as Vav3 Ϫ/Ϫ M presented a severely reduced capacity to bind sICAM-1 compared with WT M. In contrast to this finding, a previous report on phagocytosis of complement-opsonized red blood cells by Vav3 Ϫ/Ϫ and Vav1 Ϫ/Ϫ Vav3 Ϫ/Ϫ M indicated that Vav3 alone has no effect on ␤ 2 -integrin-mediated phagocytosis and that even the Vav1/Vav3 double deficiency does not impair ␤ 2 -integrin-mediated adhesion to M. 31 However, this study investigated rapid phagocytosis of C3-biopsonized particles by M previously stimulated with PMA, which is known to directly activate the protein kinase C required for complement-mediated phagocytosis. 49 This may have completely compensated for the absence of upstream Vav proteins during adhesion and may have partially compensated for the lack of Vav3 during ␤ 2 -integrin-dependent phagocytosis. We here studied binding of sICAM-1 to M stimulated with fMLP, LTB4, or TNF␣, which initiate a high-affinity ICAM-1-binding state for ␤ 2 -integrins. 50 Our experimental approach using a physiologic ligand (ICAM-1) and macrophage stimuli occurring in a variety of inflammatory conditions closely reflects the adhesion-dependent phagocytosis of apoptotic PMN during wound healing, and these conditions may additionally require Vav3 signaling.
Second, binding of WT M to ICAM-1, the major ligand for Mac-1 in the phagocytic synapse resulted in the phosphorylation of Vav3, essentially required for Vav3 exchange activity and activation of Rho-GTPases. Vav3 phosphorylation in response to macrophage adhesion to ICAM-1 was reduced in macrophages with reduced CD18 expression, further strengthening the role of Vav3 as a potential downstream target of ␤ 2 -integrin-dependent signaling.
Third, colocalization of CD18 and Vav3 specifically occurred in M upon adhesion to ICAM-1 but not to fibronectin. Fourth, apart from the almost exact recapitulation of the wound healing phenotype of CD18 Ϫ/Ϫ mice with deficient phagocytic cup formation, reduced release of active TGF-␤ 1 and impaired myofibroblast-driven wound contraction, Vav3 Ϫ/Ϫ mice exhibit spontaneous ulcerations, as earlier reported for CD18 Ϫ/Ϫ mice. 10 Finally and most importantly, injection of either Vav3 Ϫ/Ϫ or CD18 Ϫ/Ϫ M into wound margins failed to rescue the wound healing defect of Vav3 Ϫ/Ϫ mice. These data unequivocally support a critical role for Vav3 as a downstream target in ␤ 2 -integrindependent signaling. However, the ␤ 2 -integrins-Vav3 axis may not exclusively mediate phagocytic synapse formation, engulfment of apoptotic PMN, and release of active TGF-␤ 1 from M, but other receptors may play a role. 51 At least, inhibition of ␤ 3 -integrins resulted in a significant, though-compared with blocking the CD18 or ICAM-1 function-markedly lesser decrease in adhesiondependent phagocytosis of apoptotic PMN and a milder impairment of active TGF-␤ 1 release by M in vitro. These data suggest ␤ 2 -integrins to preferentially, but not exclusively control these processes. Even though ␤ 3 -integrins most likely contribute to the phagocytosis of apoptotic PMN and M in vitro, their in vivo role is unclear. In contrast to a severe wound healing defect in ␤ 2 -integrin(CD18) Ϫ/Ϫ mice and LAD1 patients 15 due to a decrease in active TGF-␤ 1 , 4 ␤ 3 -integrin Ϫ/Ϫ mice were reported to present accelerated wound healing and enhanced TGF-␤ 1 release and signaling. 52 Our data show that Vav3 cell-specifically relays ␤ 2 -integrin signaling, thus fine-tuning distinct cellular functions. Although Vav3 is not required for ␤ 2 -integrin-dependent PMN functions, it is distinctly required for M recruitment and their capacity to build the phagocytic synapse efficiently. There has been a recent focus on targeting signaling molecules as an approach to modulate and rebalance inflammation in vivo. 53 Targeting Vav3 in M by agonists or antagonists may specifically modulate M recruitment and phagocytosis of apoptotic PMN with subsequent modulation of TGF-␤ 1 release, while preserving PMN recruitment, a strategy that would minimize overall immune suppression. Alternatively, as enhanced TGF-␤ 1 release from activated M is pathogenic in a variety of fibrotic conditions 54 including hypertrophic scar and keloid formation, targeting of Vav3 may be particularly beneficial for these difficult-to-treat conditions.
